文献速递外周血管介入腹部USDSA

非闭塞性肝动脉低灌注综合征诊断与介入技术的系统综述

A systematic review of diagnostic and interventional techniques in non-occlusive hepatic artery hypoperfusion syndrome.
PubMed 文献 · Abdom Radiol (NY) · 2024-05-08

该系统综述纳入15项研究共240例接受脾动脉栓塞术(SAE)治疗的非闭塞性肝动脉低灌注综合征(NOHAH)患者,评估影像诊断能力及SAE疗效。多普勒超声(DUS)在80%研究中为首选初筛工具,肝动脉阻力指数(RI)由栓塞前均值0.84降至栓塞后0.70(p < 0.001)。技术成功均经数字减影血管造影确认,弹簧圈近端放置与较低死亡率相关,作者认为近端弹簧圈放置是更优策略。

要点

  • 多普勒超声是NOHAH可靠的初筛方法,肝动脉RI均值由栓塞前0.84降至栓塞后0.70(p < 0.001)。
  • 弹簧圈用于80.8%患者、Amplatzer血管塞(AVP)用于16.3%,技术成功均经DSA确认。
  • 脾动脉弹簧圈近端放置较远端放置死亡率更低,并发症率与AVP相当(作者结论)。

核心结论

  • DUS是NOHAH可靠的筛查方法,SAE后评估显示显著改善。
  • 栓塞剂选择与放置位置显著影响患者结局,弹簧圈近端放置因死亡率较低且并发症谱与替代方法相当,作者认为这是更优策略。
  • 总体死亡率为4.58%,记录到29例主要并发症和3例次要并发症。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索PubMed、CINAHL和Scopus数据库。
  • 纳入15项研究、共240例接受栓塞治疗(使用弹簧圈或Amplatzer血管塞(AVP))的患者。
  • 评估指标包括患者人口学、栓塞技术、栓塞剂、技术成功、栓塞前后影像学表现及并发症率。

关键影像表现/征象

  • 所有病例经数字减影血管造影确认技术成功,显示肝动脉充盈延迟但无狭窄或血栓形成。
  • 肝动脉阻力指数(RI)均值由栓塞前0.84降至栓塞后0.70(p < 0.001)。

诊断标准与关键数值

  • 多普勒超声(DUS)在80%的研究中作为主要初筛工具。
  • 肝动脉阻力指数(RI)均值:栓塞前0.84 vs 栓塞后0.70(p < 0.001)。
  • 弹簧圈用于80.8%的患者,AVP用于16.3%的患者。
  • 240例患者中177例(73.8%)报告了性别,其中男性127/177(71.7%)。
  • 总体死亡率为4.58%,记录到29例主要并发症和3例次要并发症。

临床应用与阅片要点

  • DUS可作为NOHAH的初筛工具,肝动脉RI是评估栓塞前后变化的关键参数。
  • 作者认为脾动脉弹簧圈近端放置因死亡率较低且并发症谱与AVP相当,是更优策略。
  • 技术成功需经DSA确认,表现为肝动脉充盈延迟但无狭窄或血栓形成。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This systematic review aims to elucidate the diagnostic capabilities of imaging techniques in identifying Non-Occlusive Hepatic Artery Hypoperfusion Syndrome (NOHAH) and to evaluate the efficacy and outcomes of splenic artery embolization (SAE), including the choice and placement of embolic agents.

MATERIALS AND METHODS: A comprehensive literature search was conducted using PubMed, CINAHL, and Scopus databases, adhering to PRISMA guidelines. Fifteen studies encompassing 240 patients treated with embolization (using coils or Amplatzer Vascular Plugs (AVP)) were analyzed. Key metrics assessed included patient demographics, embolization techniques, embolic agents, technical success, radiologic findings pre- and post-embolization, and complication rates.

RESULTS: Among the 240 patients studied, 177 (73.8%) were reported by gender, with a majority being male (127/177, 71.7%). Doppler ultrasonography (DUS) emerged as the primary initial screening tool in 80% of studies. The hepatic arterial resistive index (RI) was a critical parameter, with mean values significantly decreasing from 0.84 pre-embolization to 0.70 post-embolization (p < 0.001). All cases confirmed technical success via digital subtraction angiography, revealing delayed hepatic arterial filling without stenosis or thrombosis. Coils were the predominant embolic agent, used in 80.8% of patients, followed by AVP in 16.3%. The overall mortality rate was 4.58%, with 29 major and 3 minor complications noted. Notably, proximal placement of coils in the splenic artery was associated with lower mortality rates compared to distal placement and showed comparable complication rates to AVPs.

CONCLUSION: DUS is a reliable screening modality for NOHAH, with post-SAE assessments showing significant improvements. The choice and location of embolization significantly impact patient outcomes, with proximal placement of coils emerging as a preferable strategy due to lower mortality rates and comparable complication profiles to alternative methods.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Torkian P, Moghadam AD, Zimmerman J, et al. A systematic review of diagnostic and interventional techniques in non-occlusive hepatic artery hypoperfusion syndrome. Abdom Radiol (NY). 2024. PMID: 38717616. doi:10.1007/s00261-024-04340-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。